Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Plus Megestrol Acetate for Atypical Endometrial Hyperplasia
NCT04607252Phase 3Terminated
- Sponsor
- Fudan University
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in Atypical endometrial hyperplasia (AEH), sponsored by Fudan University. Started Jan 2021; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT04607252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04607252.